By Wendy Van Sickle
Columbus, Ohio, Feb. 25 – BofA Finance LLC priced $2.99 million of 0% Strategic Accelerated Redemption Securities due Feb. 28, 2025 linked to the S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Bank of America Corp.
The notes will be called at par plus a premium of 13.5% per year if the closing level of the ETF is greater than or equal to its starting value on any annual observation date.
If the notes are not called, investors will lose 1% for each 1% decline in the ETF.
BofA Securities, Inc. is the agent.
| Issuer: | BofA Finance LLC
|
| Guarantor: | Bank of America Corp.
|
| Issue: | Strategic Accelerated Redemption Securities
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $2,992,960
|
| Maturity: | Feb. 28, 2025
|
| Coupon: | 0%
|
| Price: | Par of $10
|
| Payout at maturity: | 1% loss for each 1% decline in the ETF
|
| Call: | At par plus premium of 13.5% per year if ETF closes at or above its initial value on any annual observation date
|
| Initial value: | $88.68
|
| Pricing date: | Feb. 22
|
| Settlement date: | March 1
|
| Agent: | BofA Securities, Inc.
|
| Fees: | 2%
|
| Cusip: | 09710F330
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
